Vasopressin deficiency via neurolobectomy normalizes blood pressure in hypertensive rats, induces hypotension in normotensive Wistar rats.
Background
The role of arginine vasopressin (AVP), primarily known for osmoregulation, in maintaining vascular tone and regulating blood pressure in both basal and hypertensive states remains a subject of debate. Current treatments for hypertension often target various pathways, but the direct contribution of AVP to sustained blood pressure control, beyond its acute effects, is not fully understood. This study aimed to clarify AVP's long-term influence on blood pressure by examining the effects of chronic AVP deficiency.
Study Design
Researchers performed neurointermediate pituitary lobectomy in male Wistar rats (normotensive) and spontaneously hypertensive rats (SHR), comparing them to sham-operated controls. The intervention, neurointermediate pituitary lobectomy, induced vasopressin deficiency. They evaluated water intake, urine output, plasma vasopressin and oxytocin levels, blood pressure, and heart rate over time. Measurements were taken at 3- and 90-days post-surgery to assess both acute and chronic effects of hormone deficiency. ELISA was likely used for hormone level quantification, and tail-cuff or telemetry for blood pressure.
Results
Neurointermediate pituitary lobectomy initially caused transient diabetes insipidus, which resolved with restored water balance. However, plasma vasopressin and oxytocin levels remained markedly reduced at both 3- and 90-days post-surgery, showing a significant decrease (p < 0.0001 vs. Sham controls). This sustained deficiency led to distinct blood pressure changes:
In normotensive Wistar rats, a sustained hypotension of approximately 27 mmHg was observed (p < 0.05). Conversely, in spontaneously hypertensive rats, the intervention normalized systolic blood pressure, resulting in a substantial reduction of approximately 50 mmHg (p < 0.001). Importantly, heart rate remained unchanged in both groups despite these significant alterations in blood pressure, indicating a specific effect on vascular tone rather than cardiac output.
Key Findings
- Neurointermediate pituitary lobectomy induced sustained reductions in plasma vasopressin and oxytocin levels at 3- and 90-days (p < 0.0001).
- Normotensive Wistar rats developed sustained hypotension, with blood pressure decreasing by ~27 mmHg (p < 0.05).
- Spontaneously hypertensive rats experienced normalized systolic blood pressure, reducing by ~50 mmHg (p < 0.001).
- Heart rate remained unchanged in both normotensive and hypertensive rats despite significant blood pressure alterations.
Why It Matters
This study provides compelling evidence that vasopressin plays a crucial and sustained role in regulating both basal blood pressure and the development of hypertension. The normalization of blood pressure in SHR through vasopressin deficiency suggests that targeting AVP pathways could offer a novel therapeutic strategy for hypertension, especially in cases where AVP overactivity contributes to elevated pressure. While a surgical intervention like neurolobectomy is not clinically translatable, these findings underscore the potential for pharmacological agents that modulate vasopressin synthesis, release, or receptor activity to manage blood pressure dysregulation. This research highlights a fundamental mechanism that could inform future drug development for cardiovascular health.
vasopressin
oxytocin
hypertension
hypotension
blood-pressure
neurolobectomy